[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Pages 14134-14135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05944]



Advisory Committee on the Medical Uses of Isotopes; Renewal

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice.


SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined 
that the renewal of the Charter for the Advisory Committee on the 
Medical Uses of Isotopes for the 2 year period commencing on March 10, 
2016, is in the public interest, in connection with duties imposed on 
the Commission by law. This action is being taken in accordance with 
the Federal Advisory Committee Act, after consultation with the 
Committee Management Secretariat, General Services Administration.

FOR FURTHER INFORMATION CONTACT: Sophie Holiday, Office of Federal and 
State Materials and Environmental Management Programs, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; Telephone (301) 415-7865; 
email [email protected].

SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide 
advice to NRC on policy and technical issues that arise in regulating 
the medical use of byproduct material for diagnosis and therapy. 
Responsibilities include providing guidance and comments on current and 
proposed NRC regulations and regulatory guidance concerning medical 
use; evaluating certain non-routine uses of byproduct material for 
medical use; and evaluating training and experience of proposed 
authorized users. The members are involved in preliminary discussions 
of major issues in determining the need for changes in NRC policy and 
regulation to ensure the continued safe use of byproduct

[[Page 14135]]

material. Each member provides technical assistance in his/her specific 
area(s) of expertise, particularly with respect to emerging 
technologies. Members also provide guidance as to NRC's role in 
relation to the responsibilities of other Federal agencies as well as 
of various professional organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.

    Dated at Rockville, Maryland, this 10th day of March 2016.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 2016-05944 Filed 3-15-16; 8:45 am]